Rhythm Pharmaceuticals Inc (RYTM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -104,937 | -55,639 | -196,539 | -149,034 | -96,130 |
| Depreciation Amortization | 503 | 252 | 1,338 | 1,066 | 762 |
| Accounts receivable | -14,326 | -8,110 | -7,570 | -13,745 | -7,145 |
| Accounts payable and accrued liabilities | 10,838 | -5,618 | 21,892 | 20,637 | 9,622 |
| Other Working Capital | -6,358 | -17,011 | -968 | -277 | -3,384 |
| Other Operating Activity | 60,943 | 41,941 | 66,172 | 51,067 | 32,611 |
| Operating Cash Flow | $-53,337 | $-44,185 | $-115,675 | $-90,286 | $-63,664 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 71,065 | 57,052 | -96,200 | -127,500 | 78,847 |
| PPE Investments | N/A | N/A | -40,953 | -40,000 | N/A |
| Investing Cash Flow | $71,065 | $57,052 | $-137,153 | $-167,500 | $78,847 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -11,195 | -4,288 | -19,917 | -14,517 | -8,947 |
| Common Stock Issued | 14,345 | 7,346 | 237,880 | 201,393 | 6,523 |
| Other Financing Activity | -9,715 | -8,458 | 0 | 34,035 | 34,034 |
| Financing Cash Flow | $-6,565 | $-5,400 | $217,963 | $220,911 | $31,610 |
| Exchange Rate Effect | 231 | 448 | 87 | 23 | -281 |
| Beginning Cash Position | 54,823 | 54,823 | 89,601 | 89,601 | 89,601 |
| End Cash Position | 66,217 | 62,738 | 54,823 | 52,749 | 136,113 |
| Net Cash Flow | $11,394 | $7,915 | $-34,778 | $-36,852 | $46,512 |
| Free Cash Flow | |||||
| Operating Cash Flow | -53,337 | -44,185 | -115,675 | -90,286 | -63,664 |
| Capital Expenditure | N/A | N/A | -40,953 | -40,000 | N/A |
| Free Cash Flow | -53,337 | -44,185 | -156,628 | -130,286 | -63,664 |